Chronic intrathecal infusions after spinal cord injury cause scarring and compression

Microscopy Research and Technique

Volumn 54, Issue 5, 2001, Pages 317-324

  Jones, Leonard L ^a   Tuszynski, Mark H ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Delivery; Evans Blue; Fibroglial scar; Gliosis; IBA1; Microglia; Tissue damage

Indexed keywords

EFFICIENCY; NEEDLES; PATIENT REHABILITATION; TISSUE; TUBING;

DELIVERY; EVANS BLUE; FIBROGLIAL SCAR; GLIOSIS; IBA1; INTRATHECAL; MICROGLIA; SPINAL CORD INJURY; SPINAL-CORD; TISSUE DAMAGE;

CATHETERS;

EVANS BLUE; POLYETHYLENE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CATHETER; CHRONICITY; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; FEMALE; INFUSION; NONHUMAN; PRIORITY JOURNAL; RAT; SCAR FORMATION; SPINAL CORD; SPINAL CORD COMPRESSION; SPINAL CORD INJURY; TISSUE INJURY;

RODENTIA; TRIXIS;

EID: 0035450226     PISSN: 1059910X     EISSN: None     Source Type: Journal    
DOI: 10.1002/jemt.1144     Document Type: Article

References (33)

1. Arruda JL, Sweitzer S, Rutkowski MD, DeLeo JA. 2000. Intrathecal anti-IL-6 antibody and IgG attenuates peripheral nerve injury-induced mechanical allodynia in the rat: possible immune modulation in neuropathic pain(1). Brain Res 879:216-225.
2. Banati RB, Newcombe J, Gunn RN, Cagnin A, Turkheimer F, Heppner F, Price G, Wegner F, Giovannoni G, Miller DH, Perkin GD, Smith T, Hewson AK, Bydder G, Kreutzberg GW, Jones T, Cuzner ML, Myers R. 2000. The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity. Brain 123:2321-2337.
3. Bennett G, Serafini M, Burchiel K, Buchser E, Classen A, Deer T, Du Pen S, Ferrante FM, Hassenbusch SJ, Lou L, Maeyaert J, Penn R, Portenoy RK, Rauck R, Willis KD, Yaksh T. 2000. Evidence-based review of the literature on intrathecal delivery of pain medication. J Pain Sympt Manage 20:812-36.
4. Bethea JR, Nagashima H, Acosta MC, Briceno C, Gomez F, Marcillo AE, Loor K, Green J, Dietrich WD. 1999. Systemically administered interleukin-10 reduces tumor necrosis factor- alpha production and significantly improves functional recovery following traumatic spinal cord injury in rats. J Neurotrauma 16:851-863.
5. Blesch A, Grill RJ, Tuszynski MH. 1998. Neurotrophin gene therapy in CNS models of trauma and degeneration. Prog Brain Res 117: 473-484.
6. Bowes M, Tuszynski MH, Conner J, Zivin JA. 2000. Continuous intrathecal fluid infusions elevate NGF levels and prevent functional deficits after spinal cord ischemia. Brain Res 883:178-183.
7. Bradbury EJ, Khemani S, Von R, King VR, Priestley JV, McMahon SB. 1999. NT-3 promotes growth of lesioned adult rat sensory axons ascending in the dorsal columns of the spinal cord. Eur J Neurosci 11:3873-3883.
8. Christensen MD, Hulsebosch CE. 1997a. Chronic central pain after spinal cord injury. J Neurotrauma 14:517-537.
9. Christensen MD, Hulsebosch CE. 1997b. Spinal cord injury and anti-NGF treatment results in changes in CGRP density and distribution in the dorsal horn in the rat. Exp Neurol 147:463-475.
10. Fawcett JW, Asher RA. 1999. The glial scar and central nervous system repair. Brain Res Bull 49:377-391.
11. Huang D, Han Y, Rani MR, Glabinski A, Trebst C, Sorensen T, Tani M, Wang J, Chien P, O'Bryan S, Bielecki B, Zhou ZL, Majumder S, Ransohoff RM. 2000. Chemokines and chemokine receptors in inflammation of the nervous system: manifold roles and exquisite regulation. Immunol Rev 177:52-67.
12. Ito D, Imai Y, Ohsawa K, Nakajima K, Fukuuchi Y, Kohsaka S. 1998. Microglia-specific localisation of a novel calcium binding protein, Ibal. Brain Res Mol Brain Res 57:1-9.
13. Jakeman LB, Wei P, Guan Z, Stokes BT. 1998. Brain-derived neurotrophic factor stimulates hindlimb stepping and sprouting of cholinergic fibers after spinal cord injury. Exp Neurol 154:170-184.
14. Jones LL, Kreutzberg GW, Raivich G. 1998. Transforming growth factor beta's 1, 2 and 3 inhibit proliferation of ramified microglia on an astrocyte monolayer. Brain Res 795:301-306.
15. Jones LL, Sajed D, Tuszynski MH. 2000. Differential Axonal Interactions with NG2: Enhanced Penetration with Neurotrophins. Abstr Soc Neurosci 2000 26:(abstr 508.2, p 1354).
16. King VR, Bradbury EJ, McMahon SB, Priestley JV. 2000. Changes in truncated trkB and p75 receptor expression in the rat spinal cord following spinal cord hemisection and spinal cord hemisection plus neurotrophin treatment. Exp Neurol 165:327-341.
17. Kishino A, Ishige Y, Tatsuno T, Nakayama C, Noguchi H. 1997. BDNF prevents and reverses adult rat motor neuron degeneration and induces axonal outgrowth. Exp Neurol 144:273-286.
18. Kreutzberg GW. 1996. Microglia: a sensor for pathological events in the CNS. Trends Neurosci 19:312-318.
19. Le Corre P, Estebe JP, Chevanne F, Malledant Y, Le Verge R. 1995. Spinal controlled delivery of bupivacaine from DL-lactic acid oligomer microspheres. J Pharm Sci 84:75-78.
20. Lemons ML, Howland DR, Anderson DK. 1999. Chondroitin sulfate proteoglycan immunoreactivity increases following spinal cord injury and transplantation. Exp Neurol 160:51-65.
21. Liu Y, Murray M, Tessler A, Fischer I. 2000. Grafting of genetically modified fibroblasts into the injured spinal cord. Prog Brain Res 128:309-319.
22. Logan A, Baird A, Berry M. 1999. Decorin attenuates gliotic scar formation in the rat cerebral hemisphere. Exp Neurol 159:504-510.
23. Mucke L, Eddleston M. 1993. Astrocytes in infectious and immune-mediated diseases of the central nervous system. FASEB J 7:1226-1232.
24. Novikova L, Novikov L, Kellerth JO. 1997. Effects of neurotransplants and BDNF on the survival and regeneration of injured adult spinal motoneurons. Eur J Neurosci 9:2774-2777.
25. Ohsawa K, Imai Y, Kanazawa H, Sasaki Y, Kohsaka S. 2000. Involvement of iba1 in membrane ruffling and phagocytosis of macrophages/microglia. J Cell Sci 113:3073-3084.
26. Rabchevsky AG, Fugaccia I, Fletcher-Turner A, Blades DA, Mattson MP, Scheff SW. 1999. Basic fibroblast growth factor (bFGF) enhances tissue sparing and functional recovery following moderate spinal cord injury. J Neurotrauma 16:817-830.
27. Rabchevsky AG, Fugaccia I, Turner AF, Blades DA, Mattson MP, Scheff SW. 2000. Basic fibroblast growth factor (bFGF) enhances functional recovery following severe spinal cord injury to the rat. Exp Neurol 164:280-291.
28. Ramer MS, Priestley JV, McMahon SB. 2000. Functional regeneration of sensory axons into the adult spinal cord. Nature 403:312-316.
29. Romero MI, Smith GM. 1998. Adenoviral gene transfer into the normal and injured spinal cord: enhanced transgene stability by combined administration of temperature-sensitive virus and transient immune blockade. Gene Ther 5:1612-1621.
30. Szczepanik AM, Funes S, Petko W, Ringheim GE. 2001. IL-4, IL-10 and IL-13 modulate Abeta(1-42)-induced cytokine and chemokine production in primary murine microglia and a human monocyte cell line. J Neuroimmunol 113:49-62.
31. Taricco M, Adone R, Pagliacci C, Telaro E. 2000. Pharmacological interventions for spasticity following spinal cord injury. Cochrane Database Syst Rev 2.
32. Weidner N, Blesch A, Grill RJ, Tuszynski MH. 1999a. Nerve growth factor-hypersecreting Schwann cell grafts augment and guide spinal cord axonal growth and remyelinate central nervous system axons in a phenotypically appropriate manner that correlates with expression of L1. J Comp Neurol 413:495-506.
33. Weidner N, Grill RJ, Tuszynski MH. 1999b. Elimination of basal lamina and the collagen "scar" after spinal cord injury fails to augment corticospinal tract regeneration. Exp Neurol 160:40-50.